Trial Profile
Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jul 2019
Price :
$35
*
At a glance
- Drugs CYD TDV (Primary) ; DTP-HepB-IPV-Hib vaccine LG Chem; Hepatitis A vaccine; MMR-varicella zoster virus vaccine; Pneumococcal vaccine conjugate; Yellow fever vaccine
- Indications Dengue; Diphtheria; Haemophilia; Hepatitis A; Measles; Mumps; Pertussis; Pneumococcal infections; Poliomyelitis; Rubella; Tetanus; Yellow fever
- Focus Pharmacodynamics
- Sponsors Sanofi Pasteur
- 01 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2013 Planned end date changed from 1 Dec 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 05 Feb 2013 Planned End Date changed from 1 Jan 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.